Dr. Vassilios Papadopoulos - D.Pharm., Ph.D.
Consultant

Dr. Papadopoulos received his Diploma in Pharmacy from the University of Athens, Greece and his Ph.D. in Health and Life Sciences from the University Pierre & Marie Curie (Paris VI), France. He did postdoctoral training in biochemical endocrinology at Prince of Wales Hospital, University of New South Wales, Australia. He then joined as a faculty Georgetown University Medical Center (GUMC) where he raised through the ranks to the level of Professor. In 2003, he was elected Chair of the Department of Biochemistry and Molecular Biology at GUMC and in 2004, he was appointed Associate Vice President for Research. In 2005, he was appointed the Director of the newly founded Biomedical Graduate Research Organization at GUMC. In July 2007 he moved to Montreal as the Director of the Research Institute at McGill University Health Center (MUHC), Associate Executive Director for Research at MUHC and Professor of Medicine at the McGill University Faculty of Medicine.

Dr. Papadopoulos’ has published over 200 papers and has numerous awarded and submitted patents on applications of his research in reproduction and development, cancer, stress-related disorders, aging and brain related dysfunction, such as Alzheimer’s disease pathology, and infectious diseases. In 2002, Dr. Papadopoulos was elected a member of the National Academy of Pharmacy, France, for assigning a physiological function to a drug binding protein and his studies on the pharmacological regulation of steroid biosynthesis. In 2004, he received the Biotechnology leadership award from Georgetown University and in 2007 he was awarded a Canada Research Chair in Biochemical Pharmacology from the Government of Canada.

Dr. Papadopoulos has trained numerous fellows and students, has published extensively and holds numerous patents. He has lectured throughout the world in academia, industry and scientific meetings. He served and serves on review committees of various governments, foundations and agencies and on the Editorial Board of various scientific journals. He served on the Board of Directors and Advisory Boards of biotechnology companies and he is a regular consultant for the pharmaceutical industry.

Back to Science and Technology Advisory Committee